BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2433677)

  • 41. [One case of adult Kawasaki disease].
    Zhou Y; Sun L; Yu X; Yan Z; Huang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):431-2. PubMed ID: 22561560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M; Harada K; Yamaguchi H; Yanagawa H; Sonobe T; Kawasaki T
    Prog Clin Biol Res; 1987; 250():433-9. PubMed ID: 3321083
    [No Abstract]   [Full Text] [Related]  

  • 43. Kawasaki disease.
    Narayanan SN; Krishnaveni ; Sabarinathan K
    Indian Pediatr; 1997 Feb; 34(2):139-43. PubMed ID: 9255010
    [No Abstract]   [Full Text] [Related]  

  • 44. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy.
    Asano T; Ogawa S
    Scand J Immunol; 2000 Jan; 51(1):98-103. PubMed ID: 10632983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Japanese gamma globulin trials for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Prog Clin Biol Res; 1987; 250():425-32. PubMed ID: 3321082
    [No Abstract]   [Full Text] [Related]  

  • 46. New developments in Kawasaki disease.
    Leung DY
    Curr Opin Rheumatol; 1991 Feb; 3(1):46-55. PubMed ID: 1710476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kawasaki disease associated with gallbladder hydrops.
    Coşkun Y; Bayraktaroğlu Z; Gökalp A; Cil A; Ozkutlu S
    Turk J Pediatr; 1995; 37(3):269-73. PubMed ID: 7502367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Autoantibodies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)].
    Saji T; Umezawa T; Hashiguchi R; Matsuo N
    Arerugi; 1983 Dec; 32(12):1129-33. PubMed ID: 6678147
    [No Abstract]   [Full Text] [Related]  

  • 51. [Kawasaki disease: recent findings in etiology, pathogenesis and therapy].
    Di Piero G; Bellisario G; Di Maggio M; Garibaldi G; Isola ML; Pauselli F; Proia R
    Pediatr Med Chir; 1989; 11(2):209-17. PubMed ID: 2668907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988.
    Pediatr Infect Dis J; 1989 Oct; 8(10):663-7. PubMed ID: 2682502
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J; Szymanowska Z; Mazurek A
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incomplete Kawasaki disease: a pediatric diagnostic conflict.
    Celik U; Alhan E; Arabaci F
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunological status of children with Kawasaki syndrome.
    Esser M; Cotton M; Bouic P
    S Afr Med J; 1992 Feb; 81(4):229-30. PubMed ID: 1738916
    [No Abstract]   [Full Text] [Related]  

  • 56. [New therapeutic aspects in Kawasaki syndrome and personal experiences].
    Neudorf U
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():137-9. PubMed ID: 8499743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM; Schaffer FM; Myones BL; Yount WJ; Rowe RD; Rubin L; Stein LD; Gelfand EW; Silverman ED
    Prog Clin Biol Res; 1987; 250():175-84. PubMed ID: 3423037
    [No Abstract]   [Full Text] [Related]  

  • 58. Kawasaki disease after burns.
    Ito S; Anze M; Ishikawa A; Aihara Y; Yokota S
    Eur J Pediatr; 2006 May; 165(5):340-1. PubMed ID: 16557404
    [No Abstract]   [Full Text] [Related]  

  • 59. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities.
    Marasini M; Pongiglione G; Gazzolo D; Campelli A; Ribaldone D; Caponnetto S
    Am J Cardiol; 1991 Sep; 68(8):796-7. PubMed ID: 1716411
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnosis and management of children with Kawasaki disease.
    Gidding SS; Shulman ST
    Heart Dis Stroke; 1994; 3(4):210-5. PubMed ID: 7921666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.